Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2026-01-25 @ 5:23 PM
Study NCT ID:
NCT04262804
Status:
UNKNOWN
Last Update Posted:
2023-08-22
First Post:
2020-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
Sponsor:
Zai Lab (Shanghai) Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ZL-1302-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None